Sinha Uma
Insider CIK 1742587 · EIDX Chief Scientific Officer, Director · BBIO Chief Scientific Officer · PROK Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PROK PROKIDNEY CORP. | A Award deriv | 2026-05-28 | 2026-05-29 | 135,000 | — | $0 | 135,000 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2025-05-29 | 2025-06-02 | 125,862 | — | $0 | 125,862 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2024-05-30 | 2024-06-03 | 62,558 | — | $0 | 62,558 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2023-06-29 | 2023-07-03 | 48,128 | — | $0 | 48,128 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award | 2022-07-11 | 2022-07-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | D To issuer deriv | 2021-01-26 | 2021-01-28 | 60,000 | — | $0 | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | U Tender | 2021-01-26 | 2021-01-28 | 303,525 | — | $0 | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 4,934 | $124.72 | $615.4K | 308,825 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 696 | $121.11 | $84.3K | 315,829 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 572 | $122.27 | $69.9K | 315,257 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 1,498 | $123.48 | $185.0K | 313,759 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 2,000 | $125.35 | $250.7K | 306,825 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-15 | 300 | $126.39 | $37.9K | 306,525 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 8,912 | — | $0 | 8,912 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 5,717 | — | $0 | 5,717 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 10,832 | — | $0 | 10,832 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 702 | $90.63 | $63.6K | 317,025 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 300 | $91.89 | $27.6K | 316,725 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 200 | $92.97 | $18.6K | 316,525 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 3,798 | $89.63 | $340.4K | 317,727 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 469 | — | $0 | 6,563 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 469 | — | $0 | 16,460 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 3,700 | $72.60 | $268.6K | 321,525 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,300 | $71.90 | $93.5K | 325,225 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | G Gift | 2020-10-27 | 2021-01-28 | 3,000 | — | $0 | 303,525 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-10-01 | 2020-10-02 | 4,831 | $52.35 | $252.9K | 326,525 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-09-30 | 2020-10-02 | 100 | $52.00 | $5.2K | 331,356 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2020-09-30 | 2020-10-02 | 69 | $52.08 | $3.6K | 331,456 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-08-16 | 2020-08-18 | 468 | — | $0 | 7,032 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-08-16 | 2020-08-18 | 468 | — | $0 | 15,991 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-01 | 2020-06-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2020-05-31 | 2020-06-05 | 444 | $41.57 | $18.5K | 331,525 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 49,765 | — | $0 | 49,765 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 3,022 | — | $0 | 3,022 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 5,366 | — | $0 | 5,366 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 49,361 | — | $0 | 49,361 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2020-05-19 | 2020-05-21 | 1,523 | — | $0 | 15,523 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-18 | 2019-12-20 | 1,702 | $63.31 | $107.8K | 331,081 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-18 | 2019-12-20 | 825 | $62.49 | $51.6K | 332,783 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-12-18 | 2019-12-20 | 9,973 | $61.61 | $614.4K | 333,608 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-09-25 | 2019-09-27 | 2,400 | $38.38 | $92.1K | 343,681 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-09-25 | 2019-09-27 | 100 | $39.15 | $3.9K | 343,581 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 2,967 | $35.65 | $105.8K | 348,114 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 1,300 | $36.53 | $47.5K | 346,814 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 700 | $37.31 | $26.1K | 346,114 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-07-25 | 2019-07-29 | 33 | $38.35 | $1.3K | 346,081 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2019-07-01 | 2019-07-03 | 14,000 | $17.00 | $238.0K | 14,000 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2019-05-31 | 2019-07-29 | 1,769 | $12.01 | $21.2K | 351,081 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-05-23 | 2019-05-28 | 800 | $27.88 | $22.3K | 349,312 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | S Sale | 2019-05-23 | 2019-05-28 | 4,200 | $27.16 | $114.1K | 350,112 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award | 2018-11-30 | 2019-05-28 | 1,081 | $12.01 | $13.0K | 354,312 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2018-11-05 | 2018-11-07 | 60,000 | — | $0 | 60,000 | SEC↗ |